SPOTLIGHT -
Irvine, CA-India-based Lupin Pharmaceuticals will promote gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan) in the pediatric specialty area in the United States.
Keratoconus in a pediatric population has higher prevalence than expected
ROP: Treating and preventing blindness in preterm babies
Partners collaborate on integration of AI-supported ROP telemedicine globally
Managing a changing landscape of IRD pediatric cases
An approach to preventing progression of pediatric myopia
AAO 2023: Phase III CHAMP and more trials pioneering myopia management in children